Latest filing published 28 Feb 2019 for Antares Pharma, INC., €642k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jacques Gonella: trading record in brief
All filings by Jacques Gonella on record concern Antares Pharma, Inc. The record holds 49 filings, for trades running from 24 March 2008 to 26 February 2019.
Market trades split into 1 purchase (€64k) and 26 sales (€6.6M). Sales outweigh purchases by €6.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 16 option exercises. 2019 to date brings no purchases and 1 sale.
The latest filing, published on 28 February 2019, reports an open-market sale of €642k in Antares Pharma, Inc. The last purchase on record was published on 21 March 2016, which is 3,884 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jacques Gonella
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ US$3.659.6% of flowCommon StockSEC:0001209191-19-014615:0
- 400,000 shares@ US$3.7919.7% of flowCommon StockSEC:0001209191-18-054297:0
- 49,507 shares@ US$3.092.0% of flowCommon StockSEC:0001209191-18-046882:0
- 250,493 shares@ US$3.0910.0% of flowCommon StockSEC:0001209191-18-046267:0
- 565 shares@ US$2.950.0% of flowCommon StockSEC:0001209191-18-038837:0
- 100,000 shares@ US$2.693.4% of flowCommon StockSEC:0001209191-18-037537:0
- 100,000 shares@ US$2.773.5% of flowCommon StockSEC:0001209191-18-037537:1
- 23,129 shares@ US$2.700.8% of flowCommon StockSEC:0001209191-18-036498:0
- 20,259 shares@ US$2.700.7% of flowCommon StockSEC:0001209191-18-036498:1
- 56,612 shares@ US$2.701.9% of flowCommon StockSEC:0001209191-18-035892:0
- 100,000 shares@ US$2.653.3% of flowCommon StockSEC:0001209191-18-035892:1
- 100,000 shares@ US$2.553.2% of flowCommon StockSEC:0001209191-18-035892:2
- 100,000 shares@ US$2.553.2% of flowCommon StockSEC:0001209191-18-034804:0
- 78,938 shares@ US$2.602.6% of flowCommon StockSEC:0001209191-18-034804:1
- 5,318 shares@ US$2.530.2% of flowCommon StockSEC:0001209191-18-033101:0
- 94,682 shares@ US$2.533.0% of flowCommon StockSEC:0001209191-18-033101:1
- 100,000 shares@ US$2.503.2% of flowCommon StockSEC:0001209191-18-033101:2
- 21,062 shares@ US$2.600.7% of flowCommon StockSEC:0001209191-18-032398:0
- 100,000 shares@ US$2.523.1% of flowCommon StockSEC:0001209191-18-031509:0
- 100,000 shares@ US$2.553.2% of flowCommon StockSEC:0001209191-18-031509:1
- 100,000 shares@ US$2.503.1% of flowCommon StockSEC:0001209191-18-030650:0
- 100,000 shares@ US$2.503.1% of flowCommon StockSEC:0001209191-18-030650:1
- 100,000 shares@ US$2.362.9% of flowCommon StockSEC:0001209191-18-029991:0
- 100,000 shares@ US$2.473.1% of flowCommon StockSEC:0001209191-18-029991:1
- 150,000 shares@ US$2.464.6% of flowCommon StockSEC:0001209191-18-029645:0
25 of 49 declarations
